• Summary and work group considerations Cite CITE Title : Summary and work group considerations Personal Author(s) : Grohskopf, Lisa A. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA) Published Date : February 27, 2019 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/78078 Grohskopf, Lisa A. (2019). Summary and work group considerations. 201901(010306). Grohskopf, Lisa A. "Summary and work group considerations" 201901, no. 010306 (2019) Grohskopf, Lisa A. "Summary and work group considerations" vol. 201901, no. 010306, 2019 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 261.07 KB] Personal Author: Grohskopf, Lisa A. February 27, 2019 | ACIP meeting Influenza Description: flu-6-Grohskopf-508.pdf File Type: [PDF - 261.07 KB] File Type: [PDF - 261.07 KB] Influenza surveillance update Cite CITE Title : Influenza surveillance update Personal Author(s) : Brammer, Lynnette Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA) Published Date : February 27, 2019 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/78074 Brammer, Lynnette (2019). Influenza surveillance update. 201901(010302). Brammer, Lynnette "Influenza surveillance update" 201901, no. 010302 (2019) Brammer, Lynnette "Influenza surveillance update" vol. 201901, no. 010302, 2019 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 915.91 KB] Personal Author: Brammer, Lynnette February 27, 2019 | ACIP meeting Influenza Description: flu-2-Brammer-508.pdf File Type: [PDF - 915.91 KB] File Type: [PDF - 915.91 KB] Interim estimates of 2018–19 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network Cite CITE Title : Interim estimates of 2018–19 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network Personal Author(s) : Flannery, Brendan;Chung, Jessie R.;Doyle, Joshua D.; Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). US Flu VE Network. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA) Published Date : February 27, 2019 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/78075 Flannery, Brendan et al. (2019). Interim estimates of 2018–19 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network. 201901(010303). Flannery, Brendan and Chung, Jessie R. and Doyle, Joshua D. "Interim estimates of 2018–19 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network" 201901, no. 010303 (2019) Flannery, Brendan et al. "Interim estimates of 2018–19 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network" vol. 201901, no. 010303, 2019 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 424.94 KB] Personal Author: Flannery, Brendan ; Chung, Jessie R. ... February 27, 2019 | ACIP meeting Influenza Description: flu-3-Flannery-508.pdf File Type: [PDF - 424.94 KB] File Type: [PDF - 424.94 KB] Influenza session Cite CITE Title : Influenza session Personal Author(s) : Walter, Emmanuel B.;Hills, Susan L.;; Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Influenza Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA) Published Date : February 27, 2019 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/78073 Walter, Emmanuel B. and Hills, Susan L.; (2019). Influenza session. 201901(010301). Walter, Emmanuel B. and Hills, Susan L.; "Influenza session" 201901, no. 010301 (2019) Walter, Emmanuel B. and Hills, Susan L.; "Influenza session" vol. 201901, no. 010301, 2019 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 167.83 KB] Personal Author: Walter, Emmanuel B. ; Hills, Susan L.; February 27, 2019 | ACIP meeting Influenza Description: flu-1-Walter-508.pdf File Type: [PDF - 167.83 KB] File Type: [PDF - 167.83 KB] Afluria Quadrivalent (Afluria QIV) : PHASE III, randomized, observer-blind comparator-controlled study, children 6 –59 months Cite CITE Title : Afluria Quadrivalent (Afluria QIV) : PHASE III, randomized, observer-blind comparator-controlled study, children 6 –59 months Personal Author(s) : Sylvester, Gregg C. Corporate Authors(s) : Seqirus. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA) Published Date : February 27, 2019 Series : ACIP meeting Influenza URL : https://stacks.cdc.gov/view/cdc/78076 Sylvester, Gregg C. (2019). Afluria Quadrivalent (Afluria QIV) : PHASE III, randomized, observer-blind comparator-controlled study, children 6 –59 months. 201901(010304). Sylvester, Gregg C. "Afluria Quadrivalent (Afluria QIV) : PHASE III, randomized, observer-blind comparator-controlled study, children 6 –59 months" 201901, no. 010304 (2019) Sylvester, Gregg C. "Afluria Quadrivalent (Afluria QIV) : PHASE III, randomized, observer-blind comparator-controlled study, children 6 –59 months" vol. 201901, no. 010304, 2019 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 950.24 KB] Personal Author: Sylvester, Gregg C. February 27, 2019 | ACIP meeting Influenza Description: flu-4-Sylvester-508.pdf File Type: [PDF - 950.24 KB] File Type: [PDF - 950.24 KB]

More +